What is POTS Disease? Understanding Postural Orthostatic Tachycardia Syndrome

Postural Orthostatic Tachycardia Syndrome, commonly known as POTS disease, is a condition that falls under a broader category of disorders characterized by orthostatic intolerance. Orthostatic intolerance occurs when individuals experience symptoms upon standing that are alleviated by lying down. These symptoms, frequently including dizziness and fainting, arise because insufficient blood returns to the heart when transitioning from a reclined or seated position to an upright posture.

A hallmark symptom of POTS is an accelerated heartbeat. Specifically, an individual’s heart rate may surge by 30 beats per minute or more, or exceed 120 beats per minute, within ten minutes of standing. This rapid heart rate typically subsides when the person returns to a lying position. For adolescents, the diagnostic threshold for POTS is an increase of at least 40 beats per minute.

Beyond a racing heart, POTS can manifest in a range of debilitating symptoms that often occur when standing. These include lightheadedness, dizziness, and fainting spells, alongside heart palpitations. Furthermore, individuals with POTS may suffer from profound exhaustion, persistent headaches, and a variety of other symptoms that significantly impact daily life. Some may experience blurred vision or tunnel vision, weakness in the legs, chest pain or other unexplained pain, chronic fatigue, sleep disturbances, digestive problems, shortness of breath, and difficulty concentrating, often referred to as “brain fog.” The physical challenges presented by POTS, particularly the increased heart rate and episodes of dizziness or fainting in an upright position, can make exercise and physical activity exceedingly difficult.

It’s important to note that POTS symptoms can fluctuate in intensity over time, following a relapsing-remitting pattern. While the trajectory of POTS varies, in many instances, symptoms tend to improve gradually over time. However, for some individuals, certain symptoms may persist or become long-lasting, requiring ongoing management and care.

Who is More Likely to Develop Postural Tachycardia Syndrome (POTS)?

While POTS can affect anyone, certain populations are more susceptible. Understanding these risk factors can aid in earlier recognition and diagnosis.

Age and Gender Predominance: POTS predominantly affects individuals between 15 and 50 years of age. Notably, it is significantly more prevalent in women than in men, although the reasons for this gender disparity are still under investigation.
Triggering Events: The onset of POTS is often linked to specific events such as pregnancy, major surgical procedures, puberty, physical trauma, or viral infections. Anecdotal evidence also suggests that some women experience a worsening of POTS symptoms in the days leading up to their menstrual periods, indicating a potential hormonal influence.
Genetic Predisposition and Family History: Individuals with a family history of POTS or related conditions, such as other forms of dysautonomia, have an elevated risk of developing POTS themselves. This suggests a potential genetic component in susceptibility to the disorder.
Comorbid Conditions: POTS frequently coexists with other medical conditions. Notably, individuals diagnosed with Ehler-Danlos syndrome type III, also known as hypermobile Ehlers–Danlos syndrome (hEDS), have a higher likelihood of also being diagnosed with POTS. hEDS is an inherited connective tissue disorder stemming from defects in collagen, a vital protein in the body. Furthermore, POTS has been associated with a range of other conditions including traumatic brain injury, irritable bowel syndrome, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID, and migraine. The overlapping symptoms and potential underlying mechanisms are areas of ongoing research.
Medication Considerations: Certain medications can either trigger or exacerbate POTS symptoms. These include some anti-depressants, anti-psychotics, medications for high blood pressure and heart conditions, and diuretics. It is crucial for individuals with POTS to consult with their healthcare provider before initiating any new medication and to discuss potential impacts of current medications on their POTS symptoms before discontinuing them.

How is Postural Tachycardia Syndrome (POTS) Diagnosed and Treated?

Diagnosing Postural Orthostatic Tachycardia Syndrome (POTS)

Diagnosing POTS can be a complex process due to the overlap of its symptoms with those of other medical conditions. This diagnostic ambiguity can lead to delays in obtaining a correct diagnosis and often necessitates consultation with specialists such as cardiologists or neurologists.

The diagnostic journey typically begins with a thorough review of the patient’s medical history and a detailed discussion of their reported symptoms. Physicians will routinely measure heart rate and blood pressure, observing how these vital signs respond to postural changes, particularly when transitioning from a lying or seated position to standing.

The tilt table test is a frequently employed and valuable diagnostic tool for POTS. During this test, the patient is positioned lying flat on a specialized table that is then tilted to simulate a standing position. Throughout the test, medical professionals continuously monitor heart rate and blood pressure. A significant increase in heart rate without a corresponding significant drop in blood pressure upon tilting strongly suggests the presence of POTS. In certain cases, to rule out other conditions that may mimic POTS, additional blood tests or other laboratory investigations may be deemed necessary.

While awareness and understanding of POTS are growing within the medical community, it is still not as widely recognized as some other conditions. If you suspect you might be experiencing symptoms of POTS, it is important to discuss your concerns openly with a healthcare provider and proactively ask questions to ensure thorough evaluation and appropriate management.

Treating Postural Orthostatic Tachycardia Syndrome (POTS)

The exact underlying causes of POTS remain an area of active scientific investigation. Current treatment strategies are primarily focused on managing low blood volume and irregularities in blood flow, which are considered key contributors to POTS symptoms.

Pharmacological interventions play a role in POTS management. Medications such as fludrocortisone and midodrine are sometimes prescribed to help increase blood volume and constrict blood vessels, respectively. These medications can provide symptomatic relief, particularly in the short term. However, ongoing research is crucial to fully understand their long-term efficacy and potential side effects.

Lifestyle modifications are also integral to managing POTS symptoms and improving quality of life.

Increased Salt and Fluid Intake: Increasing dietary salt intake and ensuring adequate hydration are often recommended to help regulate blood pressure and expand blood volume. These measures can counteract the blood pooling and low blood volume characteristic of POTS.
Strategic Hydration: Drinking a substantial amount of water, such as at least 16 ounces (approximately two glasses), shortly before getting up can provide a temporary boost to blood volume and help mitigate orthostatic symptoms.
Beta-Blockers: For some individuals, beta-blocker medications may offer symptom relief. Beta-blockers work by slowing down the heart rate and reducing blood pressure. In the context of POTS, they can alleviate symptoms such as dizziness, lightheadedness, and rapid heartbeat that are triggered by standing. Beta-blockers can also improve blood flow to the brain, potentially reducing other POTS-related symptoms like brain fog, headaches, tremors, and anxiety.
Graduated Exercise and Cardiovascular Rehabilitation: Research suggests that a structured cardiovascular rehabilitation program incorporating physical activity that gradually increases in intensity can improve tolerance to standing and overall functional capacity in individuals with POTS. However, it’s important to recognize that exercise intolerance is a feature of POTS for some, and therefore, this approach may not be universally suitable and requires careful individual assessment and guidance.
Compression Garments: Wearing specialized compression garments, particularly those that extend up to the waist, can be beneficial. These garments apply external pressure to the lower body, which helps to improve blood flow and reduce heart rate, especially when standing. Compression wear aids in counteracting blood pooling in the lower extremities.

What are the Latest Updates on Postural Tachycardia Syndrome (POTS)?

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), is at the forefront of federal funding for research on the brain and nervous system. NINDS actively supports innovative research aimed at enhancing our understanding, diagnosis, and treatment of POTS. NINDS-funded research initiatives encompass a wide spectrum of topics related to POTS, including the refinement of existing treatments and the investigation of novel potential medications.

COVID-19/Long COVID and POTS

Emerging research has revealed a significant association between COVID-19 infection and the subsequent development of POTS. A subset of individuals experiencing Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), have been diagnosed with POTS. Scientists are actively investigating the underlying mechanisms that explain this link.

Several long-term neurological symptoms of POTS have been observed in the context of COVID-19, including:

Brain Fog: Characterized by difficulties with concentration, memory, and sustained focus.
Cognitive Problems: Encompassing challenges with problem-solving, decision-making, and clear thinking.
Anxiety and Depression: The chronic and often fluctuating nature of POTS symptoms can contribute to the development of mental health issues such as anxiety and depression.
Sleep Problems: Including insomnia, difficulty staying asleep, and non-restorative sleep.

Further research is imperative to develop improved diagnostic tools, treatment strategies, and preventative measures for POTS, particularly in the context of Long COVID. By elucidating how COVID-19 impacts the nervous system and contributes to POTS, scientists aim to pave the way for targeted therapies and preventative approaches for POTS and other long-term health consequences of COVID-19.

Emerging Research

Ongoing clinical trials are exploring novel treatment options for POTS. One such study is evaluating the medication pyridostigmine in comparison to a placebo for the treatment of POTS. A placebo is designed to mimic the appearance of an active medication but lacks any therapeutic ingredients. Placebos are essential in clinical research to discern the true effects of a medication from psychological or other non-specific effects.

Pyridostigmine is currently primarily indicated for the treatment of myasthenia gravis, an autoimmune neuromuscular disease causing muscle weakness. Pyridostigmine enhances muscle strength by increasing the availability of a neurotransmitter that facilitates nerve signal transmission to muscles. Researchers hypothesize that pyridostigmine may also have beneficial effects in POTS by helping to lower heart rate and stabilize blood pressure. Another ongoing research endeavor is focused on identifying distinct subtypes of POTS, understanding their underlying etiological factors, and tailoring more effective and personalized treatment strategies for each subtype.

NIH-funded researchers are actively working to develop improved diagnostic tools and testing methodologies to enhance the accuracy and timeliness of POTS diagnosis, as well as to advance personalized treatment approaches. They are also investigating the cognitive impairments or “brain fog” that is a prominent feature of POTS. Specifically, they are exploring whether differences in brain activity patterns exist between individuals with POTS and those without the condition, aiming to shed light on the neurological basis of brain fog in POTS.

Furthermore, researchers are exploring the potential role of autoimmunity in a subset of POTS cases. The autoimmune hypothesis posits that in some individuals, POTS may arise from an autoimmune reaction, where the body’s immune system mistakenly targets its own tissues. Stimulation of the vagus nerve, a major nerve that regulates various bodily functions, is being investigated as a potential strategy to modulate this overactive immune response. The vagus nerve, the longest cranial nerve in the body, extends from the brainstem to the abdomen and plays a crucial role in controlling heart rate, digestion, breathing, immune responses, and even mood regulation. Researchers are conducting studies comparing individuals with POTS and healthy controls to identify potential autoantibodies and assess the therapeutic effects of vagus nerve stimulation.

Future Directions

A deeper understanding of the pathogenesis of POTS is a critical area for future research. One avenue of investigation is the role of genetic mutations, which have been implicated in POTS in some families. However, the precise genetic and epigenetic factors contributing to POTS remain largely unknown. Epigenetics refers to changes in gene expression that are not caused by alterations in the DNA sequence itself, but rather by modifications that can switch genes “on” or “off.” Epigenetic mechanisms can influence how the body develops, functions, and responds to environmental factors. Large-scale studies are needed to elucidate why POTS exhibits familial clustering and why it disproportionately affects women.

Further research is also needed to fully characterize the contribution of the immune system to the development and progression of POTS, as well as to comprehensively assess the impact of POTS on cognitive functions and brain function.

The study of donated brain tissue from individuals who had POTS offers a valuable opportunity for researchers to investigate whether POTS causes structural or functional changes in brain regions that regulate heart rate and autonomic function. Registering to donate brain tissue after death can significantly advance scientific understanding of POTS and other neurological disorders.

Learn About Clinical Trials

Clinical trials are research studies that are essential for advancing medical knowledge and improving patient care. They provide a structured framework for evaluating new diagnostic tools, treatments, and preventative strategies. Clinical trials offer individuals with POTS the opportunity to access cutting-edge treatment approaches and contribute to the collective understanding of this condition.

Search Clinical Trials

How can I or my loved one help improve care for people with postural tachycardia syndrome (POTS)?

Participating in clinical research is a meaningful way to contribute to the advancement of knowledge and care for postural orthostatic tachycardia syndrome (POTS) and related disorders. Clinical research involving human participants is crucial for researchers to gain deeper insights into POTS and to identify more effective and safer methods for detecting, treating, and preventing the condition.

Participation is needed from individuals of all backgrounds—those who are healthy, as well as those who may have an illness or disease—spanning diverse ages, sexes, races, and ethnicities. This broad representation ensures that research findings are applicable to the widest possible population and that treatments developed will be safe and effective for everyone who may benefit from them.

For comprehensive information about participating in clinical research, please visit NIH Clinical Research Trials and You. To explore clinical trials currently recruiting participants with postural orthostatic tachycardia syndrome (POTS), please visit Clinicaltrials.gov.